Register
Login:
Share:
Email Facebook Twitter


EXCLUSIVE: David Lenigas answers investor questions in a detailed interview about UKOG, Doriemus, LGC Capital, AfriAg and Angus Energy.


Cloudtag Inc Share Chat (CTAG)


CTAG Share Chat
CTAG Share Chat
CTAG Level 2 Console
CTAG Level 2 Console
CTAG Live Share Price
CTAG Live Share Price
Buy CTAG Shares
Buy CTAG Shares
Add CTAG to Watchlist
Add CTAG to Watchlist
Add CTAG to Alert
Add CTAG to Alert
Close Info Alerts is a Premium Feature
Login or start your FREE trial today.
Add CTAG to myTerminal
Add CTAG to myTerminal

There is currently no data for Cloudtag Inc.


Share Discussion for Cloudtag Inc


Thread View

Please login or register to post a message on Share Chat.

Posts per page:


dougal66
Posts: 19,149
Off Topic
Opinion:No Opinion
Price:0.00
RE: .
Sat 17:23
dnd2136

'They' are moving into an area much much bigger than the Track & App

That's what
 
dnd2136
Posts: 1,550
Off Topic
Opinion:No Opinion
Price:0.00
.
Sat 09:38
anyone understand what there trying to do now as i dont have a clue what there going on about
dougal66
Posts: 19,149
Off Topic
Opinion:No Opinion
Price:0.00
RE: Latest
Fri 07:39
edit

Lots of questions re 19 Oct 2017 Update

Coming back to 6 Oct 2017

<Cloudtag is pleased to confirm that the technical pilot with a multinational medical device and pharmaceutical manufacturing company commenced in September. Further updates on the status and outcome of this programme will be made available to shareholders via Cloudtag.com.> 6 Oct 2017
dougal66
Posts: 19,149
Off Topic
Opinion:No Opinion
Price:0.00
RE: Latest
Fri 07:37
Lots of questions re 18 Oct 2017 Update

Coming back to 6 Oct 2017

<Cloudtag is pleased to confirm that the technical pilot with a multinational medical device and pharmaceutical manufacturing company commenced in September. Further updates on the status and outcome of this programme will be made available to shareholders via Cloudtag.com.> 6 Oct 2017
AJH61
Posts: 37
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:0.00
Latest
Thu 16:41
Amit Ben-Haim: What is the importance of Clinical Studies in Cloudtag£s strategy?
A main differentiator for Cloudtag vs other £ more lifestyle focused technology companies, is our scientific rigour and the emphasize we put on accuracy and efficacy of our solutions. Accurate collection of data has been discussed for a long time in the wearable market and many companies have taken the approach of £good enough for recreational use£. We believe that a higher level of data accuracy is needed or otherwise you fall into the trap of £garbage in £ garbage out£ when you look to provide diagnostics and insights. Specifically in the weight-management area, our B2B partners are interested in the efficacy of our solution, ie delivering user engagement and sustainable weight-loss for patients that require it.
One area that we are increasingly focusing on is Behaviour Change Techniques (BCT£s) that we use in our digital platform. We believe that these can make the biggest contribution to sustainable health benefits such as weight loss. We have already shown how these BCT£s work and their impact in our first single-arm clinical study and we expect to share more on this in the future.
Cloudtag are spending a lot of time and effort conducting scientific clinical studies with patients to investigate and optimise these measures of our solution. We will continue to do so in larger scale and more global settings.
This article is part of a series of interviews and you can read Amit Ben-Haim£s previous interview here.
Cloudtag Inc. Amit Ben-Haim +1 345 949 45 44 contact@cloudtag.com
UK Investor Relations. +44 (0) 20 7052 8469 investors@cloudtag.com
AJH61
Posts: 37
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:0.00
Latest
Thu 16:40
19th October 2017
Amit Ben-Haim: What is Cloudtag£s proposition for the healthcare sector?
There are various use-cases in the healthcare service where we believe we can add value, both to the patients and to the health clinicians. For now, we are focusing on two key use-cases:
£ Secondary care Pre/post-surgery telemedicine
Many surgeries have been shown to have different success chances based on patient lifestyle in the days and weeks before and after the procedure. These commonly include activity level, diet, cardio-vascular effort and weight management. The Onitor eco-system provides clinicians with an easy way of £prescribing£ and monitoring these behaviours to increase successful outcomes from the clinical procedure.
£ Primary care pre-diabetic intervention
GP£s and other primary care providers often face patients with pre-clinical conditions and risk-factors that require an intervention but not necessarily a procedure/surgery/medication. These interventions can prevent deterioration in the patient£s condition into a chronic one which then becomes harder and more expensive to treat / manage. The Onitor eco-system provides such an preventive intervention
Amit Ben-Haim: What is Cloudtag£s proposition for the insurance sector?
Life insurance providers are finding it more and more challenging to deal with the increased health risk of NCD (non-communicable chronic diseases) without increasing premiums in a competitive market. The old model of pre-screening, risk-premium and annual renewals does not provide the level of engagement that is needed. There are specific use-cases that we are targeting:
£ Early intervention
People£s risk factors change and insurers want to know about it as soon as possible. The ability to monitor key behaviours and health indicators on a regular basis directly from the members£ body means that insurers get an opportunity to intervene early before clinical conditions materialise and claims cost start ramping up. Examples are: activity levels, weight change, heart rate issues and even sleep patterns.
£ Incentivising and monitoring healthy lifestyle
We have seen a lot of activity from insurers, sometimes alongside employers, to try and incentivise healthy lifestyle using wearables and digital programmes to achieve win-win scenarios. However, we are still in an initial phase where the benefits are presumed vs proven and insurers are still more focused on acquisition and engagement than on reduction in health risk / claims. Cloudtag are developing digital programmes for this market, focusing on weight-management as a key Diabetes Type II risk factor. We hope to be able to provide the protection providers with a scientifically proven tool that they could deploy to their members and realise health and financial benefits in the short, medium and long term.
Amit Ben-Haim: What is the importance of Clinical Studies in Cloudtag£s
No.1SS
Posts: 1,633
Off Topic
Opinion:Hold
Price:0.00
RE: Just popped by
Thu 15:35
In my opinion, I don't ever see this relisting.

This will be sold, and £££'s will appear inside our share accounts.

IMO DYOR etc.
elcap
Posts: 260
Off Topic
Opinion:No Opinion
Price:0.00
Just popped by
Thu 15:31
to check that somebody is keeping the fire burning on this BB.

One day I will click on CTAG and BOOM, there will be an RNS saying "We're Back!".

What a pleasant surprise that would be.

Forever hopeful.

Elcap
dougb189
Posts: 2,838
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:0.00
RE: latest
Thu 14:45
Give it 5 minutes peeps & enter stage left, one spotty petulant youth......




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.